Substances banned in competition

SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION

IN ADDITION TO THE CLASSES S0 TO S5 AND M1 TO M3 DEFINED ABOVE, THE FOLLOWING CLASSES ARE PROHIBITED IN-COMPETITION:

PROHIBITED SUBSTANCES

S6. STIMULANTS

All stimulants, including all optical isomers, e.g. d- and l- where relevant, are

prohibited.

Stimulants include:

a: Non-Specified Stimulants:

Adrafinil;

Amfepramone;

Amfetamine;

Amfetaminil;

Amiphenazole;

Benfluorex;

Benzylpiperazine;

Bromantan;

Clobenzorex;

Cocaine;

Cropropamide;

Crotetamide;

Fencamine;

Fenetylline;

Fenfluramine;

Fenproporex;

Fonturacetam [4-phenylpiracetam (carphedon)];

urfenorex;

Lisdexamfetamine;

Mefenorex;

Mephentermine;

Mesocarb;

Metamfetamine(d-);

p-methylamfetamine;

Modafinil;

Norfenfluramine;

Phendimetrazine;

Phentermine;

Prenylamine;

Prolintane.

A stimulant not expressly listed in this section is a Specified Substance

b: Specified Stimulants: <\>

Including, but not limited to:

3-Methylhexan-2-amine (1,2-dimethylpentylamine); v

4-Methylhexan-2-amine (methylhexaneamine);

4-Methylpentan-2-amine (1,3-dimethylbutylamine);

5-Methylhexan-2-amine (1,4-dimethylpentylamine);

Benzfetamine; <\>

Cathine**;

Cathinone and its analogues, e.g. mephedrone, methedrone, and α -

pyrrolidinovalerophenone;

Dimetamfetamine;

Ephedrine***;

Epinephrine**** (adrenaline);

Etamivan;

Etilamfetamine;

Etilefrine;

Famprofazone;

Fenbutrazate;

Fencamfamin;

Heptaminol;

Hydroxyamfetamine (parahydroxyamphetamine);

Isometheptene; <\\p>

Levmetamfetamine;

Meclofenoxate;

Methylenedioxymethamphetamine;

Methylephedrine***;

 

Methylphenidate;

Nikethamide;

Norfenefrine;

Octopamine;

Oxilofrine (methylsynephrine);

Pemoline;

Pentetrazol;

Phenethylamine and its derivatives;

Phenmetrazine;

Phenpromethamine;

Propylhexedrine;

Pseudoephedrine*****;

Selegiline;

Sibutramine;

Strychnine;

Tenamfetamine (methylenedioxyamphetamine); <\strong>

Tuaminoheptane;

 

and other substances with a similar chemical structure or similar biological effect(s).

Except: <\strong>

• Clonidine;

• Imidazole derivatives for topical/ophthalmic use and those stimulants included in the 2019 Monitoring Program*

* Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are included in the 2018 Monitoring Program, and are not considered Prohibited Substances.

** Cathine is prohibited when its concentration in urine is greater than 5 micrograms per milliliter.

*** Ephedrine and methylephedrine is prohibited when its concentration in urine is greater than 10 micrograms per milliliter.

**** Epinephrine (adrenaline) not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration with local anaesthetic agents.

***** Pseudoephedrine is prohibited when its concentration in urine is greater than 150 micrograms per milliliter.

S7. NARCOTICS <\strong>

The following narcotics are prohibited:

Buprenorphine;

Dextromoramide;

Diamorphine (heroin);

Fentanyl and its derivatives;

Hydromorphone;

Methadone;

Morphine;

Nicomorphine;

Oxycodone;

Oxymorphone;

Pentazocine;

Pethidine.

S8. CANNABINOIDS <\strong>

The following cannabinoids are prohibited:

• Natural cannabinoids, e.g. cannabis, hashish and marijuana,

• Synthetic cannabinoids e.g. Δ9-tetrahydrocannabinol (THC) and other cannabimimetics.

Except: <\strong>

• Cannabidiol.

S9. GLUCOCORTICOSTEROIDS <\strong>

All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or

rectal routes.

Including but not limited to:

Betamethasone;

Budesonide;

Cortisone;

Deflazacort;

Dexamethasone;

Fluticasone;

Hydrocortisone;

Methylprednisolone;

Prednisolone;

Prednisone;

Triamcinolone.

Page last modified on: Jan 09, 2019